MULTIMAB
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 Oct 2022)
What this means for you
Registered since 05 Apr 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86484787
- Registration number
- 4933619
- Mark type
- Stylized text
- Filed
- 18 Dec 2014
- Published for opposition
- 26 May 2015
- Registered
- 05 Apr 2016
- Attorney of record
- Keith A. Weltsch, Esq.
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Owner
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
Prosecution history
- 05 Apr 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Oct 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Oct 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Oct 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Apr 2022 — TEAS SECTION 8 & 15 RECEIVED
- 08 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Apr 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Apr 2016 — REGISTERED-PRINCIPAL REGISTER
- 10 Mar 2016 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 02 Mar 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Mar 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Feb 2016 — STATEMENT OF USE PROCESSING COMPLETE